PanGen Biotech Inc. (KOSDAQ:222110)
South Korea
· Delayed Price · Currency is KRW 6,010.00
-190.00 (-3.06%)
At close: Apr 28, 2026
PanGen Biotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 80,965 | 75,568 | 73,520 | 73,462 | 69,405 | 99,783 | Upgrade
|
| Market Cap Growth | 36.76% | 2.79% | 0.08% | 5.85% | -30.44% | 1.96% | Upgrade
|
| Enterprise Value | 68,124 | 63,258 | 69,814 | 74,767 | 67,446 | 92,638 | Upgrade
|
| Last Close Price | 6000.00 | 5600.00 | 5700.00 | 6880.00 | 6500.00 | 9350.00 | Upgrade
|
| PE Ratio | 41.10 | 36.85 | 77.91 | - | - | - | Upgrade
|
| Forward PE | - | 91.30 | 91.30 | 91.30 | 91.30 | 91.30 | Upgrade
|
| PS Ratio | 6.03 | 5.63 | 5.01 | 10.04 | 10.68 | 12.57 | Upgrade
|
| PB Ratio | 2.71 | 2.53 | 2.95 | 5.85 | 4.03 | 4.73 | Upgrade
|
| P/TBV Ratio | 2.81 | 2.62 | 3.05 | 6.29 | 4.10 | 4.80 | Upgrade
|
| P/FCF Ratio | - | - | 27.99 | - | - | - | Upgrade
|
| P/OCF Ratio | 426.55 | 398.12 | 24.61 | - | - | - | Upgrade
|
| EV/Sales Ratio | 5.08 | 4.72 | 4.76 | 10.22 | 10.38 | 11.67 | Upgrade
|
| EV/EBITDA Ratio | 22.92 | 21.29 | 28.06 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 45.23 | 42.00 | 68.43 | - | - | - | Upgrade
|
| EV/FCF Ratio | -182.64 | - | 26.58 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.16 | 0 | 0.89 | Upgrade
|
| Debt / EBITDA Ratio | 0.32 | 0.32 | 0.33 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 0.31 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.43 | -0.43 | -0.43 | 0.14 | -0.05 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.32 | -4.32 | -4.26 | -0.69 | 0.28 | 3.08 | Upgrade
|
| Net Debt / FCF Ratio | 34.43 | 34.43 | -4.04 | -0.47 | 0.20 | 1.14 | Upgrade
|
| Asset Turnover | 0.42 | 0.42 | 0.57 | 0.35 | 0.20 | 0.20 | Upgrade
|
| Inventory Turnover | 1.35 | 1.35 | 1.48 | 0.94 | 1.07 | 1.82 | Upgrade
|
| Quick Ratio | 5.64 | 5.64 | 4.98 | 0.42 | 1.55 | 1.28 | Upgrade
|
| Current Ratio | 8.43 | 8.43 | 7.16 | 1.72 | 7.59 | 1.57 | Upgrade
|
| Return on Equity (ROE) | 7.48% | 7.48% | 5.04% | -30.14% | -23.46% | -18.75% | Upgrade
|
| Return on Assets (ROA) | 2.98% | 2.98% | 2.49% | -12.75% | -8.97% | -5.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.59% | 9.52% | 6.69% | -27.46% | -28.62% | -22.21% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.00% | 5.00% | 3.70% | -28.10% | -23.50% | -14.10% | Upgrade
|
| Earnings Yield | 2.53% | 2.71% | 1.28% | -6.11% | -6.48% | -3.32% | Upgrade
|
| FCF Yield | -0.46% | -0.49% | 3.57% | -5.27% | -6.10% | -4.76% | Upgrade
|
| Buyback Yield / Dilution | -22.05% | -22.05% | -7.78% | -0.03% | -4.47% | -6.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.